Catalyst Wire Dossier Catalyst Wire Dossier

Meningococcal Vaccine 134612

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Meningococcal Vaccine 134612, covering 2012-05-22 to 2012-05-22. Get the full timeline:

Most recent: Clinical Trial Update: Primary Study to Demonstrate Non-inferiority and Immunogenicity of GSK Biologicals' Meningococcal Vaccine 134612 [Phase 3]

See pricing